443-87-8

Basic information

• Product Name: 3-Fluoro-2-methylphenol
• Synonyms: 3-FLUORO-2-METHYLPHENOL;3-Fluoro-2-Methyl Phenol 2-Methyl-3-Fluoro Phenol;2-Methyl-3-fluorophenol;3-Fluoro-2-methylphenol98%;3-Fluoro-2-methylphe;2-Fluoro-6-hydroxytoluene;2-Fluoro-6-hydroxytoluene, 3-Fluoro-o-cresol;Phenol,3-fluoro-2-Methyl-
• CAS NO: 443-87-8
• Molecular Formula: C₇H₇FO
• Molecular Weight: 126.13
• Product Categories: Fluorobenzene;Phenol&Thiophenol&Mercaptan;Benzenes
• Mol File: 443-87-8.mol

Chemical Properties

• Melting Point: 53.2-53.9
• Boiling Point: 188°C
• Flash Point: 78°C
• Appearance: /
• Density: 1.164
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 9.32±0.10(Predicted)
• CAS DataBase Reference: 3-Fluoro-2-methylphenol(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Fluoro-2-methylphenol(443-87-8)
• EPA Substance Registry System: 3-Fluoro-2-methylphenol(443-87-8)

Safety Data

• Hazard Codes: Xi,T,Xn
• Statements: 22-37/38-41-51
• Safety Statements: 26-39
• HazardClass: TOXIC
• Hazardous Substances Data: 443-87-8(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
3-Fluoro-2-methylphenol is used as a key intermediate in the synthesis of indole-like derivatives with ROR-gamma-t regulating activity. These derivatives have potential applications in the prevention and treatment of ROR-gamma-t-related diseases, which include various inflammatory and autoimmune disorders.
Used in Chemical Synthesis:
Due to its unique structure, 3-Fluoro-2-methylphenol can be employed as a building block in the synthesis of various organic compounds, such as pharmaceuticals, agrochemicals, and other specialty chemicals. Its reactivity and selectivity in chemical reactions make it a valuable component in the development of new molecules with desired properties.
Used in Research and Development:
3-Fluoro-2-methylphenol can be utilized in academic and industrial research settings to explore its potential applications and to gain insights into its chemical behavior. It can serve as a model compound for studying the effects of fluorination and methylation on the properties of phenolic compounds, as well as for investigating the structure-activity relationships of related molecules.

Upstream product

• 443-86-7 3-fluoro-2-methylaniline 
• 769-10-8 1-fluoro-2-methyl-3-nitrobenzene 
• 443-84-5 2,6-difluorotoluene 

Downstream Products

• 1165860-57-0 C₂₀H₁₇FN₆O₂ 
• 1221161-09-6 C₁₉H₂₂FN₃O₃ 
• 1600530-22-0 3-fluoro-4,4-dimethoxy-2-methylcyclohexa-2,5-dienone 
• 1600530-37-7 6-chloro-3-fluoro-4-methoxy-2-methylphenol 
• 887510-01-2 (2-(bromomethyl)-3-fluorophenoxy)(tert-butyl)dimethylsilane 

Relevant articles and documents

Method for synthesizing 3 - halogen -2 -alkyl phenol

The invention discloses a synthesis method of 3 -halo -2 - alkyl phenol, and belongs to the technical field of organic synthesis. At 2, 6 - dihaloalkylbenzene is used as starting material, nucleophilic substitution with dibenzyl alcohol in the presence of an inorganic base followed Pd / C hydrodebenzylation or Grignard exchange with magnesium metal in the presence of n-butylbromide/chloride followed by air/oxygen to give 3 - halo -2 - alkylphenols. The method has the advantages of high regioselectivity, good yield, simple operation process and the like, and the product purity can reach 99.5% or more.

9-AZABICYCLO [3 . 3 . 1] NONANE DERIVATIVES AS MONOAMINE REUPTAKE INHIBITORS

The present invention relates to a 9-azabicyclo[3.3.1]nonane derivative of formula (I), wherein R1 is H or C1-5alkyl; X is O or NR2, wherein R2 is H, C1-5alkyl or C2-5acyl and Ar is C6-10aryl or a 5-10 membered heteroaryl ring system, both being optionally substituted with one to three of R3-R5 independently selected from halogen, C1-5alkyl, C1-5alkoxy, C3-6cycloalkyl, C2-5alkenyl, C2-5alkynyl, CN, NO2, hydroxy, phenyl, phenoxy and phenylC1-2alkoxy, wherein said C1-5alkyl and C1-5alkoxy are optionally substituted with one to three halogens and wherein said phenyl, phenoxy and phenylC1-2alkoxy are optionally substituted with one to three substituents independently selected from halogen and methyl or two of R3-R5 at adjacent positions together form a methylenedioxy or propylene unit, with the proviso that the compounds exo-9-methyl-3-phenoxy-9-azabicyclo[3.3.1]nonane and N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H indazole-5-amine are excluded, or a pharmaceutically acceptable salt or solvate thereof. The invention also relates to pharmaceutical compositions comprising said 9-azabicyclo[3.3.1]nonane derivatives and to their use in therapy.

MONOAMINE RE-UPTAKE INHIBITORS AND METHODS RELATING THERETO

Monoamine re-uptake inhibitors and more specifically serotonin and noradrenaline re-uptake inhibitors are disclosed that have utility in the treatment of disorders of the central or peripheral nervous system in both men and women. The compounds of this invention have the structure: wherein R1, R2, R3, R4, R5, R6, m, n, W, X, Y, and Z are as defined herein, including stereoisomers, prodrugs and pharmaceutically acceptable salts, esters and solvates thereof. Also disclosed are compositions containing a compound of this invention in combination with a pharmaceutically acceptable carrier, as well as methods relating to the use thereof for inhibiting monoamine re-uptake in a subject in need thereof.

Synthesis intermediates containing a hexane ring and processes for their preparation

The present invention relates to new fluorinated hexane compounds corresponding to the following general formula (II): STR1 in which X'2, X'3 and X'4 are the same or different, and denote a halogen or a pseudohalogen, preferably a halogen, more preferably chlorine and fluorine, with the condition that, when R1 is hydroxyl, cyano, amido, imido, ethoxy, benzyloxy, cyclohexyloxy and tert-butoxy, not all the halogens can simultaneously be chlorine and R4, R3 and R5 are simultaneously equal to H; R1 denotes a hydrogen, a hydrocarbon chain such as an alkyl chain, alkoxy, cycloalkyl ether, an aromatic group, aromatic ether or an alkoxy, carbonyl, carboxyl or acyloxy, cyano, amido, imido or hydroxyl group; R4 denotes a hydrogen, a fluorine atom, a hydrocarbon chain such as, for example, an alkyl chain, an aromatic group or a carbonyl, carboxyl or carboxamide group or else a radical joined to the hexane ring by a chalcogen or by an element of Group V, preferably of the first Period, such as an amido, alkoxy or acyloxy group; in which the radicals R3 and R5, which are different or preferably the same, denote a fluorine, or preferably hydrogen, atom or also a hydrocarbon chain as defined above in the case of R4.